Complete Guide to Ketamine Therapy: Everything Patients Need to Know

Why This Guide Exists

If you are considering ketamine therapy, you probably have questions — about how it works, whether it could help you, what the experience is like, and how to navigate the growing number of treatment options. This guide is designed to give you a thorough, honest understanding of ketamine therapy from a patient's perspective, so you can make informed decisions about your care.

Ketamine therapy has emerged as one of the most significant advances in mental health treatment in decades. For people living with treatment-resistant depression, severe anxiety, PTSD, and chronic pain, it represents a genuine alternative when other treatments have not provided sufficient relief. But it is not a magic bullet, and understanding the full picture — benefits, limitations, costs, and risks — is essential before starting treatment.

What Is Ketamine and How Did It Become a Therapy?

Ketamine was first synthesized in 1962 and approved by the FDA as an anesthetic in 1970. For decades, it was used primarily in operating rooms and emergency departments, valued for its safety profile and ability to provide anesthesia without suppressing breathing. It remains on the World Health Organization's List of Essential Medicines.

The therapeutic story began in 2000, when a landmark study published in Biological Psychiatry demonstrated that a single sub-anesthetic dose of ketamine produced rapid antidepressant effects in patients with major depression. This finding was revolutionary because traditional antidepressants typically take four to eight weeks to show results, while ketamine could produce measurable improvement within hours.

Since that initial discovery, hundreds of clinical studies have investigated ketamine's therapeutic potential. The evidence base has grown substantially, leading to the FDA approval of esketamine (Spravato) nasal spray in 2019 for treatment-resistant depression, and widespread off-label use of generic ketamine in clinical settings across the country.

How Ketamine Works in the Brain

Traditional antidepressants like SSRIs and SNRIs work by modulating serotonin and norepinephrine levels. Ketamine operates through an entirely different mechanism, which is why it can help people who have not responded to conventional medications.

The Glutamate System

Ketamine primarily acts on the glutamate system by blocking NMDA (N-methyl-D-aspartate) receptors. Glutamate is the brain's most abundant excitatory neurotransmitter, and the NMDA receptor plays a central role in learning, memory, and neuroplasticity. When ketamine blocks these receptors, it triggers a cascade of downstream effects that promote rapid synaptic growth and strengthened neural connections.

Neuroplasticity and BDNF

One of the most important effects of ketamine is its ability to increase brain-derived neurotrophic factor (BDNF), a protein that supports neuron growth and survival. Depression is associated with reduced BDNF levels and decreased synaptic connectivity in key brain regions, particularly the prefrontal cortex. Ketamine appears to reverse these deficits, essentially helping the brain repair connections that depression has weakened.

The Default Mode Network

Emerging research suggests that ketamine also modulates the default mode network (DMN), a brain system associated with self-referential thinking and rumination. Overactivity in the DMN is linked to the repetitive negative thought patterns characteristic of depression. By temporarily disrupting these patterns, ketamine may create a window of psychological flexibility that supports lasting change — particularly when combined with psychotherapy.

Conditions Treated with Ketamine Therapy

Treatment-Resistant Depression

This is the most extensively studied indication for ketamine therapy. Treatment-resistant depression is generally defined as depression that has not responded adequately to at least two different antidepressant medications taken at appropriate doses for sufficient durations. Studies consistently show response rates of 60 to 70 percent in this population, which is remarkable given that these patients have already failed multiple conventional treatments.

Major Depressive Disorder

Even for depression that has not yet been classified as treatment-resistant, ketamine can be valuable — particularly when rapid relief is needed. Ketamine's speed of action makes it especially important for patients experiencing suicidal ideation, where waiting weeks for a traditional antidepressant to take effect may not be an acceptable option.

Anxiety Disorders

Research on ketamine for anxiety disorders is growing. Studies have shown promising results for generalized anxiety disorder, social anxiety disorder, and the anxiety that frequently accompanies depression. While the evidence base is not as large as for depression, many patients report significant anxiety reduction alongside mood improvement.

Post-Traumatic Stress Disorder

Ketamine has shown particular promise for PTSD, both as a standalone treatment and when combined with psychotherapy. The neuroplasticity-promoting effects of ketamine may help patients process traumatic memories more effectively, and several clinical trials have demonstrated meaningful symptom reduction.

Chronic Pain Conditions

Ketamine's NMDA receptor antagonism makes it uniquely effective for certain chronic pain conditions, particularly those involving central sensitization. Conditions that may respond include complex regional pain syndrome (CRPS), fibromyalgia, neuropathic pain, and chronic migraine. Pain treatment protocols often use different dosing regimens than those used for mood disorders.

Obsessive-Compulsive Disorder

Preliminary research suggests that ketamine may provide rapid, short-term relief from OCD symptoms. While the evidence is still emerging, some patients with treatment-resistant OCD have found meaningful benefit.

Routes of Administration

Intravenous (IV) Infusion

IV infusion is considered the gold standard for ketamine therapy. The medication is delivered directly into the bloodstream over 40 to 60 minutes, allowing precise dose control and near-complete bioavailability. IV infusions are administered in clinical settings with vital sign monitoring. A standard initial course consists of six infusions over two to three weeks.

Bioavailability: Approximately 100 percent
Typical session duration: 40 to 90 minutes plus recovery time
Setting: In-clinic only

Sublingual and Oral Tablets

Sublingual ketamine (troches or rapidly dissolving tablets) are placed under the tongue and absorbed through the oral mucosa. This is the most common form used in at-home treatment programs. Oral tablets that are swallowed have lower bioavailability due to first-pass liver metabolism but are sometimes prescribed for maintenance therapy.

Bioavailability: 25 to 35 percent (sublingual), 15 to 20 percent (oral/swallowed)
Typical session duration: 60 to 90 minutes
Setting: At-home with telehealth supervision, or in-clinic

Intramuscular (IM) Injection

IM injection delivers ketamine into the muscle, where it is absorbed into the bloodstream. It offers higher bioavailability than oral forms and does not require IV access. Some clinics prefer IM injections for their simplicity and rapid onset.

Bioavailability: Approximately 93 percent
Typical session duration: 45 to 75 minutes
Setting: In-clinic only

Nasal Spray (Esketamine / Spravato)

Spravato is the FDA-approved nasal spray formulation containing esketamine (the S-enantiomer of ketamine). Because it is FDA-approved specifically for treatment-resistant depression, it has a more defined regulatory pathway and is more likely to be partially covered by insurance. It must be administered under clinical supervision with a mandatory two-hour observation period.

Bioavailability: Approximately 48 percent
Typical session duration: Two hours (including mandatory observation)
Setting: Certified healthcare facility only

What to Expect During Treatment

Before Your First Session

Your provider should conduct a comprehensive evaluation including medical history review, current medication assessment, cardiovascular screening, mental health evaluation, and a discussion of your treatment goals. You will typically be asked to fast for four to six hours before your session and to arrange transportation, as you cannot drive after treatment.

During the Session

The ketamine experience varies by route of administration and dosage, but common elements include:

• Onset: Effects typically begin within minutes for IV and IM, or 15 to 20 minutes for sublingual forms
• Dissociation: A feeling of detachment from your body or surroundings, often described as floating or dreamlike
• Altered perception: Changes in how you perceive time, space, sounds, and visual input
• Emotional shifts: Some patients experience a release of emotions, insights, or a sense of perspective on their difficulties
• Physical sensations: Warmth, tingling, heaviness, or lightness

Not everyone experiences all of these effects, and the intensity varies considerably between individuals and between sessions. Many patients describe the experience as profoundly meaningful, while others find it simply unusual or mildly disorienting.

After the Session

You will need time to recover before leaving the clinic — typically 30 to 60 minutes after the infusion ends. You must not drive, operate heavy machinery, or make important decisions for the rest of the day. Many patients feel tired but emotionally lighter after their session. Some notice mood improvement within hours, while others observe gradual changes over the course of the initial treatment series.

Cost of Ketamine Therapy

Ketamine therapy costs vary significantly depending on the route of administration, geographic location, and provider:

• IV infusions: $400 to $800 per session, with an initial series of six sessions costing $2,400 to $4,800
• At-home sublingual programs: $150 to $400 per month, typically including medication, telehealth consultations, and monitoring
• Intramuscular injections: $300 to $600 per session
• Spravato (esketamine): $600 to $900 per session before insurance; often partially covered by insurance with prior authorization

Insurance Coverage

Generic ketamine used off-label is rarely covered by insurance. Spravato, because of its FDA approval, has a clearer path to insurance coverage, though it often requires prior authorization and documentation of treatment resistance. Some providers offer payment plans or sliding scale fees, and health savings accounts (HSAs) and flexible spending accounts (FSAs) can often be used for ketamine therapy.

Safety and Side Effects

Common Side Effects

During and shortly after treatment, common side effects include:

• Nausea (can be managed with anti-nausea medication)
• Dizziness and lightheadedness
• Elevated blood pressure (temporary, monitored during sessions)
• Dissociation and perceptual changes
• Fatigue and drowsiness
• Headache

These effects are typically transient and resolve within a few hours of treatment.

Who Should Not Receive Ketamine

Ketamine therapy is not appropriate for everyone. Contraindications include:

• Uncontrolled hypertension
• History of psychotic disorders (schizophrenia, schizoaffective disorder)
• Active substance abuse, particularly involving ketamine or other dissociatives
• Untreated hyperthyroidism
• Pregnancy
• Certain cardiovascular conditions
• Elevated intracranial pressure

A thorough medical screening should identify any contraindications before treatment begins.

Addiction and Dependence Concerns

At the controlled, low doses used in therapeutic settings under medical supervision, the risk of addiction is considered low. However, ketamine does have abuse potential, which is why medical oversight, proper screening, and adherence to established protocols are essential. Patients with a history of substance use disorders should discuss this thoroughly with their provider.

Getting Started

Step 1: Determine If You May Be a Candidate

Ketamine therapy is most commonly appropriate for patients who have tried other treatments without adequate results. Consider whether you have tried at least two different antidepressant medications, whether your current treatment plan is providing sufficient relief, and whether you have any contraindications that might preclude ketamine therapy.

Step 2: Research Providers

Look for providers with appropriate medical credentials (psychiatrists, anesthesiologists, or other physicians with specific ketamine therapy training), transparent pricing, comprehensive screening protocols, and ongoing monitoring. Our guide on choosing a ketamine clinic walks you through what to evaluate and which questions to ask your provider.

Step 3: Schedule an Evaluation

Most reputable providers begin with a thorough evaluation before committing to treatment. This is your opportunity to ask questions, discuss your history, and determine whether ketamine therapy aligns with your treatment goals.

Step 4: Prepare for Treatment

If approved, your provider will give you specific preparation instructions. These typically include fasting guidelines, transportation arrangements, medication adjustments (if necessary), and setting realistic expectations about the treatment process.

Step 5: Commit to the Process

Ketamine therapy works best as part of a comprehensive treatment plan. Many patients achieve the best outcomes when they combine ketamine with ongoing psychotherapy, particularly during the window of enhanced neuroplasticity that follows each session. Approach treatment as a process, not a one-time fix.

The Bigger Picture

Ketamine therapy represents a genuinely new approach to treating some of the most difficult and painful conditions in mental health. It is not without limitations — it does not work for everyone, it requires ongoing maintenance for most patients, and it involves real costs and real side effects. But for the millions of people who have not found relief through conventional treatments, it offers something that was not available a generation ago: a different path forward.

The most important thing you can do is educate yourself, ask questions, and work with a qualified provider who takes your care seriously. Your path through treatment will be unique, and having a solid understanding of what ketamine therapy involves puts you in the best position to navigate it successfully.

References

• Berman RM, et al. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 2000. — The landmark study demonstrating rapid antidepressant effects of ketamine
• Zarate CA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant depression. Archives of General Psychiatry, 2006. — Key clinical trial establishing ketamine's efficacy for treatment-resistant depression
• Krystal JH, et al. Ketamine: A paradigm shift for depression research and treatment. Neuron, 2019. — Comprehensive review of ketamine's mechanisms and clinical applications
• FDA approves new nasal spray medication for treatment-resistant depression. U.S. Food & Drug Administration, 2019. — FDA announcement of Spravato approval
• Ketamine for treatment-resistant depression: When and where is it safe? Mayo Clinic Proceedings, 2023. — Clinical guidance on safe use of ketamine for depression